Compare ACET & SDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ACET | SDA |
|---|---|---|
| Founded | 1947 | 2007 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Blank Checks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 28.0M | 29.6M |
| IPO Year | 2017 | 2022 |
| Metric | ACET | SDA |
|---|---|---|
| Price | $2.48 | $0.23 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $29.00 | N/A |
| AVG Volume (30 Days) | 284.0K | ★ 27.6M |
| Earning Date | 11-05-2026 | 12-17-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $21.66 |
| Revenue Next Year | N/A | $11.14 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.46 | $0.13 |
| 52 Week High | $9.97 | $2.45 |
| Indicator | ACET | SDA |
|---|---|---|
| Relative Strength Index (RSI) | 15.77 | 42.03 |
| Support Level | N/A | $0.13 |
| Resistance Level | $9.51 | $0.50 |
| Average True Range (ATR) | 0.26 | 0.08 |
| MACD | 0.08 | 0.00 |
| Stochastic Oscillator | 6.57 | 27.92 |
Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer. It is advancing a pipeline of off-the-shelf gamma delta T cells, engineered with chimeric antigen receptors (CARs), to facilitate durable activity in patients. The company's main product candidate, prulacabtagene leucel (prula-cel), is an allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, and is being developed for the potential treatment of autoimmune diseases. Additionally, it is pursuing ADI-212, a next-generation gene-edited and armored clinical candidate designed to target prostate-specific membrane antigen (PSMA).
SunCar Technology Group Inc operates digital automotive aftersales market service platform and vehicle insurance technology platform. It develops and operates online platforms that connect drivers in China with a range of aftermarket automotive services and insurance coverage options from a nationwide network of service providers. These comprehensive digital systems are built on SunCar's multi-tenant, cloud-based platform. Revenues from its continuing operations are mainly generated from providing auto eInsurance services, technology services, and auto services.